May 13, 2020 / 01:40PM GMT
Derik De Bruin - BofA Merrill Lynch, Research Division - MD of Equity Research
Hey, everyone. This is Derik De Bruin, the Life Sciences and Diagnostics Tools analyst for Bank of America. Welcome to our Virtual Vegas Health Care Conference, Day 2. Thank you, everybody, for dialing in and those of you on the line, I hope that you're enjoying this new experiment in remote conferences.
Our next company up today is Bio-Techne. With us from Bio-Techne is Chuck Kummeth, Chief Executive Officer; and Jim Hippel, Chief Financial Officer. Chuck, Jim, welcome. Thanks for being here.
Charles R. Kummeth - Bio-Techne Corporation - CEO, President & Director
Thank you.
James T. Hippel - Bio-Techne Corporation - Senior VP of Finance & CFO
You bet (inaudible)
Derik De Bruin - BofA Merrill Lynch, Research Division - MD of Equity Research
So I think -- yes, go ahead. Yes. I was going to say, Chuck, I think you've got a few slides to go through, and then I'm going to follow it
Bio-Techne Corp at Bank of America Merrill Lynch Healthcare Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot